Our company history and mission
60 Degrees Pharmaceuticals was founded in 2010 with a mission to realize new ways to improve and extend people’s lives by discovering, developing, and distributing new best-in-class medicines for the treatment and prevention of tropical diseases. The Company is now developing and commercializing products more broadly for infectious disease.
CORPORATE VALUES
We apply the same passion, energy, and culture of innovation that allowed the successful approval of ARAKODA® (tafenoquine) to making a difference in the world. We are committed to finding the tools and strategies that will help us overcome some of the planet’s greatest health challenges.
Return for investors
Our core business is delivering infectious disease drug development and commercialization while providing an attractive ROI.
Our collaborative approach
60 Degrees Pharmaceuticals has embraced an open innovation approach to reduce the time, cost, and risk needed to build a portfolio of drug discovery and development projects. We collaborate with leading research institutions to discover and develop medicines for infectious diseases.
Our vision
Our intention is to become the trusted leader in changing the practice of malaria prevention and forging new weapons to combat life-threatening infectious diseases.
60 Degrees Pharmaceuticals, LLC manufactures, markets and/or distributes 1 drug in the United States.
Arakoda
Generic name: tafenoquine
Drug class: antimalarial quinolines